Shares of Health Care sector company AbbVie moved -1.2% today, and are now trading at a price of $140.13. The large-cap stock's daily volume was 4,532,796 compared to its average volume of 4,302,773. The S&P 500 index returned a 1.0% performance.
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals worldwide. The company is based in North Chicago and has 50,000 full time employees. Its market capitalization is $247,345,266,688. AbbVie currently offers its equity investors a dividend that yields 4.2% per year.
24 analysts are following AbbVie and have set target prices ranging from $127.32 to $193.34 per share. On average, they have given the company a rating of buy. At today's prices, ABBV is trading -12.53% away from its average analyst target price of $160.21 per share.
Over the last year, ABBV shares have gone down by -4.0%, which represents a difference of -14.0% when compared to the S&P 500. The stock's 52 week high is $168.11 per share and its 52 week low is $130.96. With average free cash flows of $18.9 Billion that have been growing at an average rate of 11.7% over the last 6 years, AbbVie declining stock performance may not be reflective of the quality of its underlying business.
|Date Reported||Cash Flow from Operations ($ k)||Capital expenditures ($ k)||Free Cash Flow ($ k)||YoY Growth (%)|